Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
J Patient Rep Outcomes. 2024 Mar 26;8(1):38. doi: 10.1186/s41687-024-00703-1.
The FROM-16 is a generic family quality of life (QoL) instrument that measures the QoL impact of patients' disease on their family members/partners. The study aimed to assess the responsiveness of FROM-16 to change and determine Minimal Important Change (MIC).
Responsiveness and MIC for FROM-16 were assessed prospectively with patients and their family members recruited from outpatient departments of the University Hospital Wales and University Hospital Llandough, Cardiff, United Kingdom. Patients completed the EQ-5D-3L and a global severity question (GSQ) online at baseline and at 3-month follow-up. Family members completed FROM-16 at baseline and a Global Rating of Change (GRC) in addition to FROM-16 at follow-up. Responsiveness was assessed using the distribution-based (effect size-ES, standardized response mean -SRM) and anchor-based (area under the receiver operating characteristics curve ROC-AUC) approaches and by testing hypotheses on expected correlation strength between FROM-16 change score and patient assessment tools (GSQ and EQ-5D). Cohen's criteria were used for assessing ES. The AUC ≥ 0.7 was considered a good measure of responsiveness. MIC was calculated using anchor-based (ROC analysis and adjusted predictive modelling) and distribution methods based on standard deviation (SD) and standard error of the measurement (SEM).
Eighty-three patients with 15 different health conditions and their relatives completed baseline and follow-up questionnaires and were included in the responsiveness analysis. The mean FROM-16 change over 3 months = 1.43 (SD = 4.98). The mean patient EQ-5D change over 3 months = -0.059 (SD = 0.14). The responsiveness analysis showed that the FROM-16 was responsive to change (ES = 0.2, SRM = 0.3; p < 0.01). The ES and SRM of FROM-16 change score ranged from small (ES = 0.2; SRM = 0.3) for the distribution-based method to large (ES = 0.8, SRM = 0.85) for anchor-based methods. The AUC value was above 0.7, indicating good responsiveness. There was a significant positive correlation between the FROM-16 change scores and the patient's disease severity change scores (p < 0.001). The MIC analysis was based on data from 100 family members of 100 patients. The MIC value of 4 was suggested for FROM-16.
The results of this study confirm the longitudinal validity of FROM-16 which refers to the degree to which an instrument is able to measure change in the construct to be measured. The results yield a MIC value of 4 for FROM-16. These psychometric attributes of the FROM-16 instrument are useful in both clinical research as well as clinical practice.
FROM-16 是一种通用的家庭生活质量(QoL)工具,用于衡量患者疾病对其家庭成员/伴侣的 QoL 影响。本研究旨在评估 FROM-16 对变化的反应能力,并确定最小重要变化(MIC)。
通过在英国卡迪夫的威尔士大学医院和兰达夫大学医院的门诊部门招募患者及其家属,前瞻性地评估 FROM-16 的反应能力和 MIC。患者在基线和 3 个月随访时在线完成 EQ-5D-3L 和总体严重程度问题(GSQ)。家属在基线时完成 FROM-16,并在随访时完成 FROM-16 和全球变化评级(GRC)。使用基于分布的(效应大小 ES,标准化反应均值-SRM)和基于锚定的(受试者工作特征曲线下的面积 ROC-AUC)方法评估反应能力,并通过测试 FROM-16 变化评分与患者评估工具(GSQ 和 EQ-5D)之间预期相关性强度的假设来评估。使用 Cohen 的标准来评估 ES。AUC≥0.7 被认为是反应能力的良好衡量标准。MIC 通过基于锚定的(ROC 分析和调整预测建模)和基于标准差(SD)和测量标准误差(SEM)的分布方法来计算。
83 名患有 15 种不同健康状况的患者及其亲属完成了基线和随访问卷,并纳入反应能力分析。3 个月的 FROM-16 平均变化为 1.43(SD=4.98)。3 个月的患者 EQ-5D 平均变化为-0.059(SD=0.14)。反应能力分析表明,FROM-16 对变化具有反应性(ES=0.2,SRM=0.3;p<0.01)。FROM-16 变化评分的 ES 和 SRM 范围从分布方法的小(ES=0.2;SRM=0.3)到基于锚定方法的大(ES=0.8,SRM=0.85)。AUC 值高于 0.7,表明反应能力良好。FROM-16 变化评分与患者疾病严重程度变化评分之间存在显著正相关(p<0.001)。MIC 分析基于 100 名患者的 100 名家属的数据。建议 FROM-16 的 MIC 值为 4。该研究结果证实了 FROM-16 的纵向有效性,这是指工具能够测量待测量结构变化的程度。结果得出 FROM-16 的 MIC 值为 4。FROM-16 仪器的这些心理计量属性在临床研究和临床实践中都很有用。